{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T02:13:59Z","timestamp":1768443239379,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T00:00:00Z","timestamp":1548028800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100009634","name":"Susan G. Komen","doi-asserted-by":"publisher","award":["Susan G. Komen"],"award-info":[{"award-number":["Susan G. Komen"]}],"id":[{"id":"10.13039\/100009634","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s10549-018-05116-5","type":"journal-article","created":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T10:44:18Z","timestamp":1548067458000},"page":"229-237","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Customized breast cancer risk assessment in an ambulatory clinic: a portal for identifying women at risk"],"prefix":"10.1007","volume":"175","author":[{"given":"Anna","family":"Weiss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha","family":"Grossmith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Cutts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sage A.","family":"Mikami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna A.","family":"Suskin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Knust","family":"Graichen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Negui Arilis","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lydia E.","family":"Pace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eileen","family":"Joyce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Rhei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rochelle","family":"Scheib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brittany","family":"Bychkovsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judy E.","family":"Garber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Morganstern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3602-2351","authenticated-orcid":false,"given":"Tari A.","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,21]]},"reference":[{"issue":"4","key":"5116_CR1","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1093\/aje\/kwn143","volume":"168","author":"BL Sprague","year":"2008","unstructured":"Sprague BL, Trentham-Dietz A, Egan KM, Titus-Ernstoff L, Hampton JM, Newcomb PA (2008) Proportion of invasive breast cancer attributable to risk factors modifiable after menopause. Am J Epidemiol 168(4):404\u2013411. \n                    https:\/\/doi.org\/10.1093\/aje\/kwn143","journal-title":"Am J Epidemiol"},{"issue":"12","key":"5116_CR2","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1093\/aje\/kww145","volume":"184","author":"RM Tamimi","year":"2016","unstructured":"Tamimi RM, Spiegelman D, Smith-Warner SA, Wang M, Pazaris M, Willett WC, Eliassen AH, Hunter DJ (2016) Population attributable risk of modifiable and nonmodifiable breast cancer risk factors in postmenopausal breast cancer. Am J Epidemiol 184(12):884\u2013893. \n                    https:\/\/doi.org\/10.1093\/aje\/kww145","journal-title":"Am J Epidemiol"},{"issue":"2","key":"5116_CR3","doi-asserted-by":"publisher","first-page":"e0148761","DOI":"10.1371\/journal.pone.0148761","volume":"11","author":"ESG Azevedo","year":"2016","unstructured":"Azevedo ESG, de Moura L, Curado MP, Gomes Fda S, Otero U, Rezende LF, Daumas RP, Guimaraes RM, Meira KC, Leite Ida C, Valente JG, Moreira RI, Koifman R, Malta DC, Mello MS, Guedes TW, Boffetta P (2016) The Fraction of cancer attributable to ways of life, infections, occupation, and environmental agents in Brazil in 2020. PLoS ONE 11(2):e0148761. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0148761","journal-title":"PLoS ONE"},{"issue":"4","key":"5116_CR4","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.maturitas.2013.09.002","volume":"76","author":"LF Wilson","year":"2013","unstructured":"Wilson LF, Page AN, Dunn NA, Pandeya N, Protani MM, Taylor RJ (2013) Population attributable risk of modifiable risk factors associated with invasive breast cancer in women aged 45\u201369 years in Queensland, Australia. Maturitas 76(4):370\u2013376. \n                    https:\/\/doi.org\/10.1016\/j.maturitas.2013.09.002","journal-title":"Maturitas"},{"issue":"10","key":"5116_CR5","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1001\/jamaoncol.2016.1025","volume":"2","author":"P Maas","year":"2016","unstructured":"Maas P, Barrdahl M, Joshi AD, Auer PL, Gaudet MM, Milne RL, Schumacher FR, Anderson WF, Check D, Chattopadhyay S, Baglietto L, Berg CD, Chanock SJ, Cox DG, Figueroa JD, Gail MH, Graubard BI, Haiman CA, Hankinson SE, Hoover RN, Isaacs C, Kolonel LN, Le Marchand L, Lee IM, Lindstrom S, Overvad K, Romieu I, Sanchez MJ, Southey MC, Stram DO, Tumino R, VanderWeele TJ, Willett WC, Zhang S, Buring JE, Canzian F, Gapstur SM, Henderson BE, Hunter DJ, Giles GG, Prentice RL, Ziegler RG, Kraft P, Garcia-Closas M, Chatterjee N (2016) breast cancer risk from modifiable and nonmodifiable risk factors among white women in the United States. JAMA Oncol 2(10):1295\u20131302. \n                    https:\/\/doi.org\/10.1001\/jamaoncol.2016.1025","journal-title":"JAMA Oncol"},{"issue":"12","key":"5116_CR6","doi-asserted-by":"publisher","first-page":"e0144680","DOI":"10.1371\/journal.pone.0144680","volume":"10","author":"L Strumylaite","year":"2015","unstructured":"Strumylaite L, Sharp SJ, Kregzdyte R, Poskiene L, Bogusevicius A, Pranys D (2015) The association of low-to-moderate alcohol consumption with breast cancer subtypes defined by hormone receptor status. PLoS ONE 10(12):e0144680. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0144680","journal-title":"PLoS ONE"},{"issue":"4","key":"5116_CR7","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/S1470-2045(07)70099-2","volume":"8","author":"R Baan","year":"2007","unstructured":"Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Bouvard V, Altieri A, Cogliano V (2007) Carcinogenicity of alcoholic beverages. Lancet Oncol 8(4):292\u2013293","journal-title":"Lancet Oncol"},{"key":"5116_CR8","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/906495","author":"A Amadou","year":"2013","unstructured":"Amadou A, Hainaut P, Romieu I (2013) Role of obesity in the risk of breast cancer: lessons from anthropometry. J Oncol. \n                    https:\/\/doi.org\/10.1155\/2013\/906495","journal-title":"J Oncol"},{"issue":"2","key":"5116_CR9","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1001\/jama.296.2.193","volume":"296","author":"AH Eliassen","year":"2006","unstructured":"Eliassen AH, Colditz GA, Rosner B, Willett WC, Hankinson SE (2006) Adult weight change and risk of postmenopausal breast cancer. JAMA 296(2):193\u2013201. \n                    https:\/\/doi.org\/10.1001\/jama.296.2.193","journal-title":"JAMA"},{"issue":"1","key":"5116_CR10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3322\/caac.20140","volume":"62","author":"LH Kushi","year":"2012","unstructured":"Kushi LH, Doyle C, McCullough M, Rock CL, Demark-Wahnefried W, Bandera EV, Gapstur S, Patel AV, Andrews K, Gansler T (2012) American Cancer Society Guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin 62(1):30\u201367. \n                    https:\/\/doi.org\/10.3322\/caac.20140","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"5116_CR11","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1080\/08964289.2014.947234","volume":"42","author":"MR Andersen","year":"2016","unstructured":"Andersen MR, Thorpe J, Buist DS, Beatty JD, Watabayashi K, Hanson N, Resta R, Chubak J, Urban N (2016) Cancer risk awareness and concern among women with a family history of breast or ovarian cancer. Behav Med 42(1):18\u201328. \n                    https:\/\/doi.org\/10.1080\/08964289.2014.947234","journal-title":"Behav Med"},{"issue":"6","key":"5116_CR12","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1111\/tbj.13082","volume":"24","author":"E Hannan","year":"2018","unstructured":"Hannan E, Peter O\u2019Leary D, Cheung C, Buhamad F, O\u2019Donoghue G, Manning A, Oliver Murphy J, Hill A, Power C (2018) Knowledge of breast cancer risk factors, screening, and treatment methods in patients attending the breast clinic: a survey of 1,018 women. Breast J 24(6):1094\u20131096. \n                    https:\/\/doi.org\/10.1111\/tbj.13082","journal-title":"Breast J"},{"issue":"6","key":"5116_CR13","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.breast.2015.09.009","volume":"24","author":"J Livaudais-Toman","year":"2015","unstructured":"Livaudais-Toman J, Karliner LS, Tice JA, Kerlikowske K, Gregorich S, Perez-Stable EJ, Pasick RJ, Chen A, Quinn J, Kaplan CP (2015) Impact of a primary care based intervention on breast cancer knowledge, risk perception and concern: a randomized, controlled trial. Breast 24(6):758\u2013766. \n                    https:\/\/doi.org\/10.1016\/j.breast.2015.09.009","journal-title":"Breast"},{"issue":"4","key":"5116_CR14","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/j.1525-1497.2004.30280.x","volume":"19","author":"JS Haas","year":"2004","unstructured":"Haas JS, Kaplan CP, Gregorich SE, Perez-Stable EJ, Des Jarlais G (2004) Do physicians tailor their recommendations for breast cancer risk reduction based on patient\u2019s risk? J Gen Intern Med 19(4):302\u2013309. \n                    https:\/\/doi.org\/10.1111\/j.1525-1497.2004.30280.x","journal-title":"J Gen Intern Med"},{"issue":"2","key":"5116_CR15","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s10549-017-4115-x","volume":"162","author":"LH Rosenberger","year":"2017","unstructured":"Rosenberger LH, Weber R, Sjoberg D, Vickers AJ, Mangino DA, Morrow M, Pilewskie ML (2017) Impact of self-reported data on the acquisition of multi-generational family history and lifestyle factors among women seen in a high-risk breast screening program: a focus on modifiable risk factors and genetic referral. Breast Cancer Res Treat 162(2):275\u2013282. \n                    https:\/\/doi.org\/10.1007\/s10549-017-4115-x","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"5116_CR16","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1017\/S1478951515000164","volume":"13","author":"SR Ormseth","year":"2015","unstructured":"Ormseth SR, Wellisch DK, Arechiga AE, Draper TL (2015) Predicting reattendance at a high-risk breast cancer clinic. Palliat Support Care 13(5):1441\u20131448. \n                    https:\/\/doi.org\/10.1017\/s1478951515000164","journal-title":"Palliat Support Care"},{"issue":"3","key":"5116_CR17","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s10689-012-9530-x","volume":"11","author":"NJ Engel","year":"2012","unstructured":"Engel NJ, Gordon P, Thull DL, Dudley B, Herstine J, Jankowitz RC, Zorn KK (2012) A multidisciplinary clinic for individualizing management of patients at increased risk for breast and gynecologic cancer. Fam Cancer 11(3):419\u2013427. \n                    https:\/\/doi.org\/10.1007\/s10689-012-9530-x","journal-title":"Fam Cancer"},{"issue":"3 Pt A","key":"5116_CR18","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.jacr.2017.11.034","volume":"15","author":"DL Monticciolo","year":"2018","unstructured":"Monticciolo DL, Newell MS, Moy L, Niell B, Monsees B, Sickles EA (2018) Breast cancer screening in women at higher-than-average risk: recommendations from the ACR. J Am Coll Radiol 15(3 Pt A):408\u2013414. \n                    https:\/\/doi.org\/10.1016\/j.jacr.2017.11.034","journal-title":"J Am Coll Radiol"},{"issue":"2","key":"5116_CR19","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/j.1524-4741.2009.00690.x","volume":"15","author":"EM Ozanne","year":"2009","unstructured":"Ozanne EM, Loberg A, Hughes S, Lawrence C, Drohan B, Semine A, Jellinek M, Cronin C, Milham F, Dowd D, Block C, Lockhart D, Sharko J, Grinstein G, Hughes KS (2009) Identification and management of women at high risk for hereditary breast\/ovarian cancer syndrome. Breast J 15(2):155\u2013162. \n                    https:\/\/doi.org\/10.1111\/j.1524-4741.2009.00690.x","journal-title":"Breast J"},{"issue":"5","key":"5116_CR20","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/nrc1608","volume":"5","author":"GA Colditz","year":"2005","unstructured":"Colditz GA, Hankinson SE (2005) The Nurses\u2019 Health Study: lifestyle and health among women. Nat Rev Cancer 5(5):388\u2013396. \n                    https:\/\/doi.org\/10.1038\/nrc1608","journal-title":"Nat Rev Cancer"},{"key":"5116_CR21","unstructured":"Obesity: Preventing and managing the global epidemic. Report of a WHO consultation (2000) WHO Technical Report Series, vol\u00a0894. Geneva"},{"issue":"24","key":"5116_CR22","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1093\/jnci\/81.24.1879","volume":"81","author":"MH Gail","year":"1989","unstructured":"Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Mulvihill JJ (1989) Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81(24):1879\u20131886","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"5116_CR23","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/sim.1668","volume":"23","author":"J Tyrer","year":"2004","unstructured":"Tyrer J, Duffy SW, Cuzick J (2004) A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 23(7):1111\u20131130. \n                    https:\/\/doi.org\/10.1002\/sim.1668","journal-title":"Stat Med"},{"key":"5116_CR24","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2147\/IJWH.S23246","volume":"3","author":"SJ Hartman","year":"2011","unstructured":"Hartman SJ, Dunsiger SI, Jacobsen PB (2011) The relationship of psychosocial factors to mammograms, physical activity, and fruit and vegetable consumption among sisters of breast cancer patients. Int J Womens Health 3:257\u2013263. \n                    https:\/\/doi.org\/10.2147\/ijwh.s23246","journal-title":"Int J Womens Health"},{"key":"5116_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s12529-018-9737-9","author":"N Bertoni","year":"2018","unstructured":"Bertoni N, de Souza MC, Crocamo S, Szklo M, de Almeida LM (2018) Is a family history of the breast cancer related to women\u2019s cancer prevention behaviors? Int J Behav Med Aug. \n                    https:\/\/doi.org\/10.1007\/s12529-018-9737-9","journal-title":"Int J Behav Med Aug"},{"issue":"5","key":"5116_CR26","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.ypmed.2011.03.001","volume":"52","author":"D Spector","year":"2011","unstructured":"Spector D, Deroo LA, Sandler DP (2011) Lifestyle behaviors in black and white women with a family history of breast cancer. Prev Med 52(5):394\u2013397. \n                    https:\/\/doi.org\/10.1016\/j.ypmed.2011.03.001","journal-title":"Prev Med"},{"issue":"8","key":"5116_CR27","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s10552-013-0226-9","volume":"24","author":"G Bostean","year":"2013","unstructured":"Bostean G, Crespi CM, McCarthy WJ (2013) Associations among family history of cancer, cancer screening and lifestyle behaviors: a population-based study. Cancer Causes Control 24(8):1491\u20131503. \n                    https:\/\/doi.org\/10.1007\/s10552-013-0226-9","journal-title":"Cancer Causes Control"},{"issue":"9336","key":"5116_CR28","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S0140-6736(02)09962-2","volume":"360","author":"J Cuzick","year":"2002","unstructured":"Cuzick J, Forbes J, Edwards R, Baum M, Cawthorn S, Coates A, Hamed A, Howell A, Powles T, investigators I (2002) First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial. Lancet 360(9336):817\u2013824","journal-title":"Lancet"},{"issue":"22","key":"5116_CR29","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1093\/jnci\/dji372","volume":"97","author":"B Fisher","year":"2005","unstructured":"Fisher B, Costantino JP, Wickerham DL, Cecchini RS, Cronin WM, Robidoux A, Bevers TB, Kavanah MT, Atkins JN, Margolese RG, Runowicz CD, James JM, Ford LG, Wolmark N (2005) Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst 97(22):1652\u20131662. \n                    https:\/\/doi.org\/10.1093\/jnci\/dji372","journal-title":"J Natl Cancer Inst"},{"issue":"23","key":"5116_CR30","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1001\/jama.295.23.joc60074","volume":"295","author":"VG Vogel","year":"2006","unstructured":"Vogel VG, Costantino JP, Wickerham DL, Cronin WM, Cecchini RS, Atkins JN, Bevers TB, Fehrenbacher L, Pajon ER Jr, Wade JL III, Robidoux A, Margolese RG, James J, Lippman SM, Runowicz CD, Ganz PA, Reis SE, McCaskill-Stevens W, Ford LG, Jordan VC, Wolmark N, National Surgical Adjuvant B, Bowel P (2006) Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA 295(23):2727\u20132741. \n                    https:\/\/doi.org\/10.1001\/jama.295.23.joc60074","journal-title":"JAMA"},{"issue":"25","key":"5116_CR31","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1056\/NEJMoa1103507","volume":"364","author":"PE Goss","year":"2011","unstructured":"Goss PE, Ingle JN, Ales-Martinez JE, Cheung AM, Chlebowski RT, Wactawski-Wende J, McTiernan A, Robbins J, Johnson KC, Martin LW, Winquist E, Sarto GE, Garber JE, Fabian CJ, Pujol P, Maunsell E, Farmer P, Gelmon KA, Tu D, Richardson H, Investigators NCMS (2011) Exemestane for breast-cancer prevention in postmenopausal women. N Engl J Med 364(25):2381\u20132391. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1103507","journal-title":"N Engl J Med"},{"issue":"28","key":"5116_CR32","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1200\/JCO.2015.60.8869","volume":"33","author":"JA Tice","year":"2015","unstructured":"Tice JA, Miglioretti DL, Li CS, Vachon CM, Gard CC, Kerlikowske K (2015) Breast density and benign breast disease: risk assessment to identify women at high risk of breast cancer. J Clin Oncol 33(28):3137\u20133143. \n                    https:\/\/doi.org\/10.1200\/JCO.2015.60.8869","journal-title":"J Clin Oncol"},{"issue":"1","key":"5116_CR33","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s13058-015-0653-5","volume":"17","author":"AR Brentnall","year":"2015","unstructured":"Brentnall AR, Harkness EF, Astley SM, Donnelly LS, Stavrinos P, Sampson S, Fox L, Sergeant JC, Harvie MN, Wilson M, Beetles U, Gadde S, Lim Y, Jain A, Bundred S, Barr N, Reece V, Howell A, Cuzick J, Evans DG (2015) Mammographic density adds accuracy to both the Tyrer\u2013Cuzick and Gail breast cancer risk models in a prospective UK screening cohort. Breast Cancer Res 17(1):147. \n                    https:\/\/doi.org\/10.1186\/s13058-015-0653-5","journal-title":"Breast Cancer Res"},{"issue":"4","key":"5116_CR34","doi-asserted-by":"publisher","first-page":"279","DOI":"10.7326\/M15-2886","volume":"164","author":"AL Siu","year":"2016","unstructured":"Siu AL (2016) Screening for breast cancer: U.S. preventive services task force recommendation statement. Ann Intern Med 164(4):279\u2013296. \n                    https:\/\/doi.org\/10.7326\/m15-2886","journal-title":"Ann Intern Med"},{"issue":"1","key":"5116_CR35","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jacr.2009.09.022","volume":"7","author":"CH Lee","year":"2010","unstructured":"Lee CH, Dershaw DD, Kopans D, Evans P, Monsees B, Monticciolo D, Brenner RJ, Bassett L, Berg W, Feig S, Hendrick E, Mendelson E, D\u2019Orsi C, Sickles E, Burhenne LW (2010) Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. J Am Coll Radiol 7(1):18\u201327. \n                    https:\/\/doi.org\/10.1016\/j.jacr.2009.09.022","journal-title":"J Am Coll Radiol"},{"issue":"15","key":"5116_CR36","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1001\/jama.2015.12783","volume":"314","author":"KC Oeffinger","year":"2015","unstructured":"Oeffinger KC, Fontham ET, Etzioni R, Herzig A, Michaelson JS, Shih YC, Walter LC, Church TR, Flowers CR, LaMonte SJ, Wolf AM, DeSantis C, Lortet-Tieulent J, Andrews K, Manassaram-Baptiste D, Saslow D, Smith RA, Brawley OW, Wender R (2015) Breast cancer screening for women at average risk: 2015 guideline update From the American Cancer Society. JAMA 314(15):1599\u20131614. \n                    https:\/\/doi.org\/10.1001\/jama.2015.12783","journal-title":"JAMA"},{"issue":"18","key":"5116_CR37","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1200\/JCO.2017.75.9480","volume":"36","author":"AC Degnim","year":"2018","unstructured":"Degnim AC, Winham SJ, Frank RD, Pankratz VS, Dupont WD, Vierkant RA, Frost MH, Hoskin TL, Vachon CM, Ghosh K, Hieken TJ, Carter JM, Denison LA, Broderick B, Hartmann LC, Visscher DW, Radisky DC (2018) Model for predicting breast cancer risk in women with atypical hyperplasia. J Clin Oncol 36(18):1840\u20131846. \n                    https:\/\/doi.org\/10.1200\/jco.2017.75.9480","journal-title":"J Clin Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-018-05116-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-018-05116-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-018-05116-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T19:06:34Z","timestamp":1579547194000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-018-05116-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,21]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["5116"],"URL":"https:\/\/doi.org\/10.1007\/s10549-018-05116-5","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,21]]},"assertion":[{"value":"18 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"JA Suskin reports stock ownership in Pfizer, Thermo Fisher, and Danaher (owned by immediate family members). JE Garber reports a consultant\/advisory role for Helix Genetics. TA King reports a consultant\/advisory role for Genomic Health. None of these affiliations influenced this work. All other authors report no conflicts.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The study was approved by the Brigham and Women\u2019s Hospital Institutional Review Board as a low risk study and approved with waiver of consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}